Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye

NCT00560638 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: loteprednol etabonate ophthalmic suspension, 0.5%
DRUG: loteprednol etabonate ophthalmic suspension, 0.5%
DRUG: vehicle of loteprednol etabonate

Sponsor

Bausch & Lomb Incorporated